Background Limited data are available describing human papillomavirus (HPV) genotype
distributions in cervical cancer in the United States. Such studies are needed to predict how …

The age-specific occurrence of cervical cancer related to human papillomavirus (HPV)
genotypes HPV16 and HPV18, the two targeted by current HPV vaccines, is not well …

Currently, two prophylactic human papillomavirus (HPV) vaccines targeting HPV 16 and 18
have been shown to be highly efficacious for preventing precursor lesions although the …

Background. Two vaccines protect against human papillomaviruses (HPV) 16 and 18, which
cause 70% of cervical cancer and 50% of cervical intraepithelial neoplasia 2/3 and …

Determining the causal attribution of human papillomavirus (HPV) genotypes to cervical
disease is important to estimate the effect of HPV vaccination and to establish a type …

Background Cervical screening programs use testing for human papillomavirus (HPV)
genotypes. Different HPV types differ greatly in prevalence and oncogenicity. We estimated …

Background Prospective data on the risks of cervical precancer associated with specific
human papillomavirus (HPV) genotypes are limited Methods In 5060 women participating in …

Persistent cervical infections with carcinogenic human papillomaviruses (HPV) cause
virtually all cervical cancer. Cytologic abnormalities are the manifestations of HPV infections …

Oncogenic human papillomavirus (HPV) infections, the necessary cause of most cervical
cancers, are common and usually clear within 1 to 2 years. Identifying cofactors that lead to …

Background: We estimated the prevalence and incidence of 14 human papillomavirus (HPV)
types (6/11/16/18/31/33/35/39/45/51/52/56/58/59) in cervicovaginal swabs, and the …